195 related articles for article (PubMed ID: 19367256)
1. Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.
Gau CL; Rosenblatt RA; Cerullo V; Lay FD; Dow AC; Livesay J; Brunetti-Pierri N; Lee B; Cederbaum SD; Grody WW; Lipshutz GS
Mol Ther; 2009 Jul; 17(7):1155-63. PubMed ID: 19367256
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy.
Lee EK; Hu C; Bhargava R; Rozengurt N; Stout D; Grody WW; Cederbaum SD; Lipshutz GS
Mol Ther; 2012 Oct; 20(10):1844-51. PubMed ID: 22760543
[TBL] [Abstract][Full Text] [Related]
3. Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy.
Hu C; Tai DS; Park H; Cantero G; Cantero-Nieto G; Chan E; Yudkoff M; Cederbaum SD; Lipshutz GS
Gene Ther; 2015 Feb; 22(2):111-5. PubMed ID: 25474440
[TBL] [Abstract][Full Text] [Related]
4. Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse.
Kasten J; Hu C; Bhargava R; Park H; Tai D; Byrne JA; Marescau B; De Deyn PP; Schlichting L; Grody WW; Cederbaum SD; Lipshutz GS
Mol Genet Metab; 2013 Nov; 110(3):222-30. PubMed ID: 23920045
[TBL] [Abstract][Full Text] [Related]
5. Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice.
Hu C; Kasten J; Park H; Bhargava R; Tai DS; Grody WW; Nguyen QG; Hauschka SD; Cederbaum SD; Lipshutz GS
Mol Ther; 2014 Oct; 22(10):1792-802. PubMed ID: 24888478
[TBL] [Abstract][Full Text] [Related]
6. Mouse model for human arginase deficiency.
Iyer RK; Yoo PK; Kern RM; Rozengurt N; Tsoa R; O'Brien WE; Yu H; Grody WW; Cederbaum SD
Mol Cell Biol; 2002 Jul; 22(13):4491-8. PubMed ID: 12052859
[TBL] [Abstract][Full Text] [Related]
7. Inducible arginase 1 deficiency in mice leads to hyperargininemia and altered amino acid metabolism.
Sin YY; Ballantyne LL; Mukherjee K; St Amand T; Kyriakopoulou L; Schulze A; Funk CD
PLoS One; 2013; 8(11):e80001. PubMed ID: 24224027
[TBL] [Abstract][Full Text] [Related]
8. Strategies to rescue the consequences of inducible arginase-1 deficiency in mice.
Ballantyne LL; Sin YY; St Amand T; Si J; Goossens S; Haenebalcke L; Haigh JJ; Kyriakopoulou L; Schulze A; Funk CD
PLoS One; 2015; 10(5):e0125967. PubMed ID: 25938595
[TBL] [Abstract][Full Text] [Related]
9. AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse.
Lee EK; Hu C; Bhargava R; Ponnusamy R; Park H; Novicoff S; Rozengurt N; Marescau B; De Deyn P; Stout D; Schlichting L; Grody WW; Cederbaum SD; Lipshutz GS
Gene Ther; 2013 Aug; 20(8):785-96. PubMed ID: 23388701
[TBL] [Abstract][Full Text] [Related]
10. Rescue of the Functional Alterations of Motor Cortical Circuits in Arginase Deficiency by Neonatal Gene Therapy.
Cantero G; Liu XB; Mervis RF; Lazaro MT; Cederbaum SD; Golshani P; Lipshutz GS
J Neurosci; 2016 Jun; 36(25):6680-90. PubMed ID: 27335400
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.
Truong B; Allegri G; Liu XB; Burke KE; Zhu X; Cederbaum SD; Häberle J; Martini PGV; Lipshutz GS
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21150-21159. PubMed ID: 31501335
[TBL] [Abstract][Full Text] [Related]
12. Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
Khoja S; Nitzahn M; Hermann K; Truong B; Borzone R; Willis B; Rudd M; Palmer DJ; Ng P; Brunetti-Pierri N; Lipshutz GS
Mol Genet Metab; 2018 Aug; 124(4):243-253. PubMed ID: 29801986
[TBL] [Abstract][Full Text] [Related]
13. Ornithine deficiency in the arginase double knockout mouse.
Deignan JL; Livesay JC; Yoo PK; Goodman SI; O'Brien WE; Iyer RK; Cederbaum SD; Grody WW
Mol Genet Metab; 2006; 89(1-2):87-96. PubMed ID: 16753325
[TBL] [Abstract][Full Text] [Related]
14. Hepatic glutamine synthetase augmentation enhances ammonia detoxification.
Soria LR; Nitzahn M; De Angelis A; Khoja S; Attanasio S; Annunziata P; Palmer DJ; Ng P; Lipshutz GS; Brunetti-Pierri N
J Inherit Metab Dis; 2019 Nov; 42(6):1128-1135. PubMed ID: 30724386
[TBL] [Abstract][Full Text] [Related]
15. Arginine to ornithine ratio as a diagnostic marker in patients with positive newborn screening for hyperargininemia.
Huang Y; Sharma R; Feigenbaum A; Lee C; Sahai I; Sanchez Russo R; Neira J; Brooks SS; Jackson KE; Wong D; Cederbaum S; Lacbawan FL; Rowland CM; Tanpaiboon P; Salazar D
Mol Genet Metab Rep; 2021 Jun; 27():100735. PubMed ID: 33732618
[TBL] [Abstract][Full Text] [Related]
16. Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme.
Grody WW; Kern RM; Klein D; Dodson AE; Wissman PB; Barsky SH; Cederbaum SD
Hum Genet; 1993 Mar; 91(1):1-5. PubMed ID: 8454280
[TBL] [Abstract][Full Text] [Related]
17. Human hepatocyte transplantation corrects the inherited metabolic liver disorder arginase deficiency in mice.
Angarita SAK; Truong B; Khoja S; Nitzahn M; Rajbhandari AK; Zhuravka I; Duarte S; Lin MG; Lam AK; Cederbaum SD; Lipshutz GS
Mol Genet Metab; 2018 Jun; 124(2):114-123. PubMed ID: 29724658
[TBL] [Abstract][Full Text] [Related]
18. Arginases I and II: do their functions overlap?
Cederbaum SD; Yu H; Grody WW; Kern RM; Yoo P; Iyer RK
Mol Genet Metab; 2004 Apr; 81 Suppl 1():S38-44. PubMed ID: 15050972
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia.
Deignan JL; Marescau B; Livesay JC; Iyer RK; De Deyn PP; Cederbaum SD; Grody WW
Mol Genet Metab; 2008 Feb; 93(2):172-8. PubMed ID: 17997338
[TBL] [Abstract][Full Text] [Related]
20. Correction of argininosuccinate synthetase (AS) deficiency in a murine model of citrullinemia with recombinant adenovirus carrying human AS cDNA.
Ye X; Whiteman B; Jerebtsova M; Batshaw ML
Gene Ther; 2000 Oct; 7(20):1777-82. PubMed ID: 11083500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
